Multidrug-Resistant Gram-Negative Bacterial Infections in the Hospital Setting: Overview, Implications for Clinical Practice, and Emerging Treatment Options.
about
Altered Outer Membrane Transcriptome Balance with AmpC Overexpression in Carbapenem-Resistant Enterobacter cloacaeNew insight on antimicrobial therapy adjustment strategies for gram-negative bacterial infection: A cohort study.Analysis of the third- and fourth-generation cephalosporin use for the treatment of infections caused by Gram-negative bacteria in hospital settings.Controversies and advances in the management of ventilator associated pneumonia.Infection control interventions affected by resource shortages: impact on the incidence of bacteremias caused by carbapenem-resistant pathogens.Antimicrobial activity of octenidine against multidrug-resistant Gram-negative pathogens.Influence of regular reporting on local Pseudomonas aeruginosa and Acinetobacter spp. sensitivity to antibiotics on consumption of antibiotics and resistance patterns.Activity of AMP2041 against human and animal multidrug resistant Pseudomonas aeruginosa clinical isolates.Antibiotic Susceptibility Patterns of Bacterial Isolates from Pus Samples in a Tertiary Care Hospital of Punjab, India.The Hydroalcoholic Extract Obtained from Mentha piperita L. Leaves Attenuates Oxidative Stress and Improves Survival in Lipopolysaccharide-Treated MacrophagesImipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.Effectiveness of Chinese Herbal Medicine Combined with Antibiotics for Extensively Drug-Resistant Enterobacteria and Nonfermentative Bacteria Infection: Real-Life Experience in a Retrospective Cohort.PsrA controls the synthesis of the Pseudomonas aeruginosa quinolone signal via repression of the FadE homolog, PA0506.Dynamics of Intact MexAB-OprM Efflux Pump: Focusing on the MexA-OprM Interface.Short proline-rich lipopeptide potentiates minocycline and rifampicin against multidrug- and extensively drug-resistant Pseudomonas aeruginosa.Multidrug-resistant gram-negative bacterial infections in a teaching hospital in Ghana.Effect of Fractioning on Antibacterial Activity of Enantia chlorantha Oliver (Annonaceae) Methanol Extract and Mode of Action.Antibacterial and Antibiotic-Potentiating Activities of Thirteen Cameroonian Edible Plants against Gram-Negative Resistant PhenotypesLower neutrophil-to-lymphocyte ratio predicts high risk of multidrug-resistant infection in patients with hospital-acquired pneumonia
P2860
Q37528489-A83ECD10-C6F0-4B09-A9EA-8F0AF81B1EB6Q37737270-48AC9DAD-4A35-433D-B5ED-B75A96AF3A2EQ39054761-96C33E63-1552-4211-9082-419B08DF1B24Q40054170-A0D4BED8-02AF-4AC0-828C-EC86CD103B5DQ40063160-6A2B2067-019B-41ED-8B41-095DD3223F4EQ40086085-1C03C33D-D8A7-4589-9640-9B1EA4587515Q40194123-3A5B8378-1995-4813-9A88-F0E20ED415FAQ40281147-216D1144-B602-44CD-A9E7-D614B22B924FQ40441399-33E0F621-D08C-4837-B802-F0BFC8BC3CB6Q42709137-D60B3F3B-A841-425E-9CD8-A7AEF38A1A87Q46243175-93A800B2-8C2C-43BB-B204-B3BC8D2486C8Q46743417-A60D8DFA-5F7B-4F12-AC59-52D5FD1AEBB4Q47095721-8395F3C5-6EC7-44FB-BD3B-3093E2368548Q47133688-55BE25F8-485C-47DF-85E1-627C416AFCA1Q50044323-E877EFC2-65F8-4B06-BA59-84509B06E4FBQ54255705-33B7EB74-F5AC-4CF0-9CDB-9AB52E1F1D7DQ54959997-60D11053-545A-4495-8E85-D3DA3A91E17AQ57114947-0425116B-C99E-4D19-B366-5734F1D8E03EQ57485307-EDD035EA-3C68-4094-80D5-8F92BF07B328
P2860
Multidrug-Resistant Gram-Negative Bacterial Infections in the Hospital Setting: Overview, Implications for Clinical Practice, and Emerging Treatment Options.
description
2016 nî lūn-bûn
@nan
2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Multidrug-Resistant Gram-Negat ...... nd Emerging Treatment Options.
@ast
Multidrug-Resistant Gram-Negat ...... nd Emerging Treatment Options.
@en
Multidrug-Resistant Gram-Negat ...... nd Emerging Treatment Options.
@nl
type
label
Multidrug-Resistant Gram-Negat ...... nd Emerging Treatment Options.
@ast
Multidrug-Resistant Gram-Negat ...... nd Emerging Treatment Options.
@en
Multidrug-Resistant Gram-Negat ...... nd Emerging Treatment Options.
@nl
prefLabel
Multidrug-Resistant Gram-Negat ...... nd Emerging Treatment Options.
@ast
Multidrug-Resistant Gram-Negat ...... nd Emerging Treatment Options.
@en
Multidrug-Resistant Gram-Negat ...... nd Emerging Treatment Options.
@nl
P2093
P356
P1476
Multidrug-Resistant Gram-Negat ...... nd Emerging Treatment Options.
@en
P2093
Alpesh N Amin
Bradley M Sherman
Elizabeth Cerceo
Steven B Deitelzweig
P304
P356
10.1089/MDR.2015.0220
P577
2016-02-11T00:00:00Z